Source:http://linkedlifedata.com/resource/pubmed/id/19915054
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2009-11-20
|
pubmed:abstractText |
IL-9 is a cytokine of great current interest associated with allergic/Th2 responses. High levels of IL-9 are present in bronchial secretions from infants with respiratory syncytial virus (RSV) bronchiolitis. To test its effects in RSV disease with a Th2 profile, BALB/c mice were vaccinated with recombinant vaccinia virus expressing the RSV G protein. On RSV challenge, immunized mice developed augmented disease characterized by enhanced pulmonary Th2 and local IL-9 production peaking on days 7-10 of RSV infection. Depletion with anti-IL-9 Ab at vaccination or RSV challenge enhanced viral clearance. Depletion only at challenge had no effect on disease severity, whereas depletion at immunization and challenge enhanced Th1 responses, inhibited virus-specific IgG1 production, and enhanced disease severity. By contrast, depletion of IL-9 at immunization boosted IgG2a and inhibited the Th2 response and disease during subsequent infection without a concomitant increase in type 1 cytokines. Adoptive transfer of secondary memory CD4 T cells from the spleens of IL-9-depleted mice into naive recipients replicated many of the effects of depletion, indicating that IL-9 acts via CD4 T cells. Therefore, IL-9 is a previously unknown but key modulator of antiviral immunity, regulating T and B cell responses and having potent and specific effects on viral lung disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1550-6606
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
183
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7006-13
|
pubmed:meshHeading |
pubmed-meshheading:19915054-Animals,
pubmed-meshheading:19915054-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19915054-Female,
pubmed-meshheading:19915054-Flow Cytometry,
pubmed-meshheading:19915054-Immunoglobulin G,
pubmed-meshheading:19915054-Immunologic Memory,
pubmed-meshheading:19915054-Interleukin-9,
pubmed-meshheading:19915054-Mice,
pubmed-meshheading:19915054-Mice, Inbred BALB C,
pubmed-meshheading:19915054-Respiratory Syncytial Virus Infections,
pubmed-meshheading:19915054-Respiratory Syncytial Viruses,
pubmed-meshheading:19915054-Th1 Cells,
pubmed-meshheading:19915054-Th2 Cells
|
pubmed:year |
2009
|
pubmed:articleTitle |
IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.
|
pubmed:affiliation |
Department of Respiratory Medicine, St. Mary's Campus, Imperial College, London W2 1PG, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|